Log in

NASDAQ:TRUPTrupanion Stock Price, Forecast & News

$32.94
-0.27 (-0.81 %)
(As of 05/27/2020 04:00 PM ET)
Add
Compare
Today's Range
$32.30
Now: $32.94
$34.22
50-Day Range
$25.88
MA: $29.78
$33.58
52-Week Range
$20.84
Now: $32.94
$38.06
Volume327,155 shs
Average Volume345,566 shs
Market Capitalization$1.16 billion
P/E RatioN/A
Dividend YieldN/A
Beta1.56
Trupanion, Inc., together with its subsidiaries, provides medical insurance for cats and dogs on monthly subscription basis in the United States, Canada, and Puerto Rico. The company operates through Subscription Business and Other Business segments. It serves pet owners and veterinarians through third-party referrals and online member acquisition channels. The company was formerly known as Vetinsurance International, Inc. changed its name to Trupanion, Inc. in 2013. Trupanion, Inc. was founded in 2000 and is headquartered in Seattle, Washington.
Read More
Trupanion logo

Beat the Market (BTM) Rank

Analyst Opinion: 2.3Community Rank: 2.7Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.33 out of 5 stars


Industry, Sector and Symbol

Industry Hospital & medical service plans
Sub-IndustryN/A
SectorFinance
Current SymbolNASDAQ:TRUP
CUSIPN/A
Phone855-727-9079

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$383.94 million
Cash Flow$0.11 per share
Book Value$3.90 per share

Profitability

Net Income$-1,810,000.00

Miscellaneous

Employees586
Market Cap$1.16 billion
Next Earnings Date8/4/2020 (Estimated)
OptionableOptionable

Receive TRUP News and Ratings via Email

Sign-up to receive the latest news and ratings for TRUP and its competitors with MarketBeat's FREE daily newsletter.

Trupanion (NASDAQ:TRUP) Frequently Asked Questions

How has Trupanion's stock been impacted by COVID-19 (Coronavirus)?

Trupanion's stock was trading at $26.04 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, TRUP stock has increased by 26.5% and is now trading at $32.94. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Trupanion?

8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Trupanion in the last year. There are currently 3 hold ratings and 5 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Trupanion.

When is Trupanion's next earnings date?

Trupanion is scheduled to release its next quarterly earnings announcement on Tuesday, August 4th 2020. View our earnings forecast for Trupanion.

How were Trupanion's earnings last quarter?

Trupanion Inc (NASDAQ:TRUP) announced its quarterly earnings results on Thursday, April, 30th. The financial services provider reported ($0.03) EPS for the quarter, topping the consensus estimate of ($0.04) by $0.01. The financial services provider earned $111.30 million during the quarter, compared to analyst estimates of $110.10 million. Trupanion had a negative net margin of 0.40% and a negative return on equity of 1.23%. The firm's quarterly revenue was up 28.0% compared to the same quarter last year. During the same period in the previous year, the business posted ($0.04) earnings per share. View Trupanion's earnings history.

What price target have analysts set for TRUP?

8 analysts have issued 12 month target prices for Trupanion's shares. Their forecasts range from $20.00 to $50.00. On average, they anticipate Trupanion's stock price to reach $37.57 in the next year. This suggests a possible upside of 14.1% from the stock's current price. View analysts' price targets for Trupanion.

Has Trupanion been receiving favorable news coverage?

News articles about TRUP stock have trended somewhat negative this week, according to InfoTrie Sentiment Analysis. The research group scores the sentiment of press coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Trupanion earned a news sentiment score of -1.7 on InfoTrie's scale. They also assigned press coverage about the financial services provider a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an impact on the company's share price in the near future. View the latest news aboutTrupanion.

Who are some of Trupanion's key competitors?

What other stocks do shareholders of Trupanion own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Trupanion investors own include CA (CA), McEwen Mining (MUX), Endologix (ELGX), BlackRock (BLK), Chipotle Mexican Grill (CMG), Micron Technology (MU), Baidu (BIDU), Gilead Sciences (GILD), Starbucks (SBUX) and Splunk (SPLK).

Who are Trupanion's key executives?

Trupanion's management team includes the following people:
  • Mr. Darryl Graham Andrew Rawlings, Founder, Pres, CEO & Director (Age 50)
  • Ms. Tricia Lynn Plouf, Chief Financial Officer (Age 40)
  • Mr. Thomas J. Houk, Chief Member Experience Officer (Age 31)
  • Mr. Asher Benjamin Bearman, Chief Strategy Officer & Corp. Sec. (Age 41)
  • Ms. Margaret Tooth, Chief Revenue Officer (Age 40)

What is Trupanion's stock symbol?

Trupanion trades on the NASDAQ under the ticker symbol "TRUP."

Who are Trupanion's major shareholders?

Trupanion's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Wellington Management Group LLP (9.51%), Nine Ten Capital Management LLC (8.86%), Capital World Investors (7.96%), BlackRock Inc. (5.83%), Alliancebernstein L.P. (5.47%) and Baillie Gifford & Co. (3.96%). Company insiders that own Trupanion stock include Asher Bearman, Dan Levitan, Darryl Rawlings, Gavin Friedman, H Hays Lindsley, Howard E Rubin, Margaret Tooth, Murray B Low, Robin A Ferracone and Tricia Plouf. View institutional ownership trends for Trupanion.

Which major investors are selling Trupanion stock?

TRUP stock was sold by a variety of institutional investors in the last quarter, including Morgan Stanley, Wells Fargo & Company MN, Alliancebernstein L.P., Ensign Peak Advisors Inc, Nine Ten Capital Management LLC, Lord Abbett & CO. LLC, Karani Asset Management LLC, and Handelsbanken Fonder AB. Company insiders that have sold Trupanion company stock in the last year include Asher Bearman, Dan Levitan, Darryl Rawlings, Gavin Friedman, H Hays Lindsley, Margaret Tooth, Murray B Low, and Tricia Plouf. View insider buying and selling activity for Trupanion.

Which major investors are buying Trupanion stock?

TRUP stock was bought by a variety of institutional investors in the last quarter, including Capital World Investors, Thomas Story & Son LLC, Geode Capital Management LLC, Nuveen Asset Management LLC, Massachusetts Financial Services Co. MA, First Trust Advisors LP, PNC Financial Services Group Inc., and Connors Investor Services Inc.. View insider buying and selling activity for Trupanion.

How do I buy shares of Trupanion?

Shares of TRUP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Trupanion's stock price today?

One share of TRUP stock can currently be purchased for approximately $32.94.

How big of a company is Trupanion?

Trupanion has a market capitalization of $1.16 billion and generates $383.94 million in revenue each year. The financial services provider earns $-1,810,000.00 in net income (profit) each year or ($0.05) on an earnings per share basis. Trupanion employs 586 workers across the globe.

What is Trupanion's official website?

The official website for Trupanion is www.trupanion.com.

How can I contact Trupanion?

Trupanion's mailing address is 6100 4TH AVENUE SOUTH SUITE 200, SEATTLE WA, 98108. The financial services provider can be reached via phone at 855-727-9079 or via email at [email protected]

This page was last updated on 5/28/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.